Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 467

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 467
---
 of 40,103 shares of common stock issuable upon the exercise of options within 60 days of 
 January 30, 2025.                                                                                 |

| (16) | Consists of 88,167 shares of common stock issuable upon the exercise of options within 60 days of 
 January 30, 2025.                                                                                 |

| (17) | Consists of 63,314 shares of common stock issuable upon the exercise of options within 60 days of 
 January 30, 2025.                                                                                 |

| (18) | Consists of 5,099 shares of common stock issuable upon the exercise of options within 60 days of 
 January 30, 2025.                                                                                |

| (19) | Consists of an aggregate of (i) 7,806,908 shares of common stock; (ii) 2,160,585 shares issuable upon the                                                                                                                                      
 exercise of stock options within 60 days of January 30, 2025; and (iii); 35,500 shares issuable upon the vesting of restricted stock units within 60 days of January 30, 2025 held by our current executive officers and directors as a group. |

- 317 -

PRINCIPAL STOCKHOLDERS OF AADI AFTER THE PIPE FINANCING The following table sets forth information relating to the expected beneficial ownership of our common stock immediately after closing of the PIPE Financing, assuming the closing occurred on January 30, 2025, by:

| • |     | each person, or group of affiliated persons, expected to beneficially own more than 5% of the outstanding shares 
 of our common stock, assuming closing of the PIPE Financing;                                                     |

| • |     | each of our directors; |

| • |     | each of our named executive officers; and |

| • |     | all current directors and executive officers as a group. |

The number of shares beneficially owned by each entity, person, director or executive officer is determined in accordance with the rules of the SEC, and the information is not necessarily indicative of beneficial ownership for any other purpose. Under such rules, beneficial ownership includes any shares over which the individual has sole or shared voting power or investment power as well as any shares that the individual has the right to acquire within 60 days of January 30, 2025 through the exercise of any stock option, warrants or other rights. Except as otherwise indicated, and subject to applicable community property laws, the